Posted on

Skin Tissue Arrays

Please send your request for detailed information and quote to: info@vitrovivo.com

SKU#

DESCRIPTION

CASE

CORE

PRICE ($)

ME481bMelanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 48 cases/48 cores, replaced by ME481c4848182.00
MEL501Multiple sites of malignant melanoma with skin tissue array (2018 WHO classification), including pathology grade, TNM and clinical satge (AJCC 7th edition), 50 cases/50 cores5050175.50
AC451Condyloma acuminatum and skin tissue array, 45 cases/45 cores4545214.50
SK244bAge grouped female skin tissue array, 12 cases/24 cores, replacing SK244a1224292.50
T388Malignant melanoma test tissue array, including TNM and clinical stage, 6 cases/24 cores62471.50
T388aMalignant melanoma test tissue array, including TNM and clinical stage, 6 cases/24 cores62471.50
ME1002aMalignant melanoma tissue array with normal skin tissue as control, including pathology grade, TNM and clinical stage, 50 cases/100 cores, replacing ME100250100377.00
TMA-120Malignant melanoma tissue array with skin tissue, 50 cases/100 cores50100331.50
ME483aMalignant melanoma tissue array, including TNM and clinical stage, 48 cases/48 cores, replacing ME4834848292.50
SK181aMalignant melanoma with benign nevus tissue array, including TNM and clinical stage, 18 cases/18 cores, replacing SK1811818188.50
T383bMalignant melanoma with normal skin tissue test array, including TNM and clinical stage, 6 cases/24 cores, replacing T383a62471.50
ME802Malignant melanoma with normal tissue array, 40 cases/80 cores4080331.50
ME242dMalignant melanoma with skin tissue array, including TNM and clinical stage, 24 cases/24 cores, replacing ME242c242471.50
ME481dMalignant melanoma with skin tissue array, including TNM and clinical stage, 48 cases/48 cores, replacing ME481c4848182.00
ME1002cMalignant melanoma with skin tissue array, including TNM and clinical stage, 50 cases/100 cores, replacing ME1002b50100377.00
T382bMalignant melanoma with skin tissue test array, including TNM and clinical stage, 12 cases/24 cores, replacing T382a122471.50
T382dMalignant melanoma with skin tissue test array, including TNM and clinical stage, 12 cases/24 cores, replacing T382c122471.50
MME1004iMalignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases/100 cores, replacing ME1004h100100383.50
MME981Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 98 cases/98 cores9898383.50
SK241aSkin cancer tissue array with adjacent normal skin tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing SK241122484.50
T211bSkin cancer tissue array with normal skin tissue, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T211a62452.00
ME482bSkin malignant melanoma with skin tissue array, including TNM and clinical stage, 48 cases/ 48 cores, replacing ME482a4848292.50
SKI501Skin malignant tumor with skin tissue array (2018 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 50 cases/50 cores5050221.00
SKI503Skin squamous cell carcinoma with skin tissue array (2018 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 50 cases/50 cores5050221.00
SK961Skin tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases/96 cores4896279.50
T214Skin tumor tissue array, including TNM, clinical stage and pathology grade, 6 cases/24 cores62471.50
T212aSkin tumor tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing T212122471.50
SKI-461Skin tumor with matched skin tissue array (2018 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 23 cases/46 cores2346221.00
SKI502Skin tumor with matched skin tissue array (2018 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 25 cases/50 cores5050221.00
SKI504Skin basal cell carcinoma with skin tissue array (2019 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 50 cases/50 cores5050221.00

TMA Applications:

Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH)

Notes:

1) TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2) Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.

TNM Grading

T – Primary tumor
      Tx – Primary tumor cannot be assessed
      T0 – No evidence of primary tumor
      Tis – Carcinoma in situ; intraepithelial or invasion of lamina propria
      T1 – Tumor invades submucosa
      T2 – Tumor invades muscularis propria
      T3 – Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
      T4 – Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N – Regional lymph nodes
     Nx – Regional lymph nodes cannot be assessed
     N0 – No regional lymph node metastasis
     N1 – Metastasis in 1 to 3 regional lymph nodes
     N2 – Metastasis in 4 or more regional lymph nodes

M – Distant metastasis
     Mx – Distant metastasis cannot be assessed
     M0 – No distant metastasis
     M1 – Distant metastasis

Stage of Cancer

  • Stage 0 means there’s no cancer, only abnormal cells with the potential to become cancer. This is also called carcinoma in situ.
  • Stage I means the cancer is small and only in one area. This is also called early-stage cancer.
  • Stage II and III mean the cancer is larger and has grown into nearby tissues or lymph nodes.
  • Stage IV means the cancer has spread to other parts of your body. It’s also called advanced or metastatic cancer.